Application for Emerging Companies
Applications are now open.
Abstract Submission
Welcome to the Abstract Submission portal of the Euretina Innovation Spotlight (EIS) 2026.
EIS invites submissions from emerging industry members and biotech companies to showcase their innovations in the field of retina during this event.
Selected companies will have the opportunity to showcase their business/clinical strategy on 30th September 2026, in Vienna. This is an opportunity for you to introduce your company’s strategy in developing cutting-edge treatment options for retinal diseases, moving the field forward.
This submission portal is exclusively for industry personnel and should be presented by a C-suite representative of your company.
Please carefully review the Submission Guidelines before starting your submission.
Furthermore, we would like to highlight:
• Only emerging companies that are first-time presenters at EIS are eligible to apply. Other companies should contact the sponsorship team at [email protected] for more information regarding participation in the programme.
• You may submit only one proposal.
• Presentation slots are extremely limited, and submissions will be subject to review for inclusion in the programme.
• Submitters of proposals will be informed upon acceptance via email shortly.
For any questions or technical issues during the submission process, please contact the Congress Secretariat via [email protected]